Role for ZAP-70 signaling in the differential effector functions of rituximab and obinutuzumab (GA101) in chronic lymphocytic leukemia B cells

Sladjana Skopelja-Gardner, Jonathan D. Jones, B. Jonell Hamilton, Alexey V. Danilov, William F.C. Rigby

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Role for ZAP-70 signaling in the differential effector functions of rituximab and obinutuzumab (GA101) in chronic lymphocytic leukemia B cells'. Together they form a unique fingerprint.

Medicine & Life Sciences